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Occurrence of disease is a function of several
major variables: the virulence of the microorgan-
ism (i.e., its possession of factors that allow it to
cause illness), its mode of transmission (i.e., how
it gets to the host), and host susceptibility (i.e.,
how well the host can defend itself against the
microorganism). Increased susceptibility to
infection may be measured in terms of infectious
dose (the number of microorganisms it takes to
cause illness) and of the ability of the host to limit
spread of the microorganism (e.g., the ability to
limit spread of microorganisms from the intestinal
tract to the bloodstream). These same variables
apply to emerging pathogens. Microorganisms may
emerge as pathogens because they have developed
new virulence genes or resistance to standard
therapeutic methods. Emergence may be related
to changes in transmission pathways, which
permit a known pathogen to move into new,
previously unexposed populations. Finally, in-
creases in the number of persons susceptible to a
specific microorganism may result in its emergence
as an important public health problem; at the same
time, when attention is focused on populations
with increased susceptibility to infection, organ-
isms that might not otherwise be recognized as
pathogens may be identified.
Many factors influence the susceptibility of
populations to infection, including increases in
diseases that cause immunosuppression, in-
creased use of immunosuppressive agents, aging
of the population, and malnutrition. In consider-
ing these categories, it should be recognized that
“host susceptibility” is not a single entity.  Changes
in host susceptibility may be due to various
mechanisms, with each mechanism having a
greater or lesser impact on the ability of the host
to defend itself against infection with specific
pathogens or classes of pathogens. These are very
complex biologic systems; nonetheless, the general
categories outlined below may be of value in
identifying groups or populations for further study.
Increases in Diseases That Cause
Immunosuppression
Hereditary diseases associated with immu-
nosuppression are present in a small but
relatively constant proportion of the population.
The most common of these diseases, a selective
immunoglobulin A deficiency, has been found in
as many as 0.3% of some blood donor populations
(1) and may be associated with recurrent
diarrhea; infections with giardia, in particular,
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have been noted to be more common among such
immunocompromised patients.
In contrast to patients with hereditary
immunodeficiencies, the population of patients
with acquired immunodeficiencies is rapidly
increasing. As of June 1996 in the United States,
an estimated 223,000 persons ³ 13 years of age
had AIDS (Figure 1); this represents increases of
10% and 65% since mid-1995 and January 1993,
respectively. During 1995, human immunodefi-
ciency virus (HIV) infection remained the leading
cause of death among persons 25 to 44 years of
age (Figure 2), accounting for 19% of deaths from
all causes in this age group (2).
Persons with AIDS show a clear increase in
susceptibility to infection with Salmonella
species. Data suggest that risk for nontyphi
Salmonella infections is increased 20- to 100-fold
among AIDS patients (3-7). Among persons
infected with Salmonella, AIDS results in a
severalfold increase in the risk for septicemia
(3,5,6); AIDS also results in increases in
infections at other extraintestinal sites, compati-
ble with an overall increase in risk for
dissemination of the organism. This increase in
risk is reflected in increases in the percentage of
total Salmonella isolated from blood. For
example, for persons ages 25 to 49 years in states
with high AIDS incidence, the percentage of
Salmonella isolates from blood increased from
2.3% in 1978 to 17.8% in 1987 among men and
from 3.1% to 8.1% among women; in contrast, no
changes in blood-isolate percentages occurred for
either sex in states with low AIDS incidence (8).
These latter studies further suggest that serotype is
an important risk determinant, with increases in
bacteremia in states with high AIDS incidence
associated primarily with infections due to
Salmonella Enteritidis and Salmonella Typh-
imurium. While these data are for nontyphoidal
Salmonella, studies outside the United States
suggest that AIDS patients have a similar
increase in risk for infection with Salmonella
typhi in areas endemic for typhoid fever. For
example, in Lima, Peru, the risk for typhoid
increased 25-fold in HIV-infected persons 15 to 35
years of age (9); HIV infection also appeared to
influence the clinical presentation of typhoid
fever, with severe diarrhea and gastrointestinal
symptoms seen more often than expected.
 While the above data suggest a continuing
climb in salmonellosis and, in particular,
Salmonella bacteremia in conjunction with an
increasing AIDS prevalence, anecdotal data from
AIDS clinicians do not support this view. The
standard of care for AIDS patients now includes
routine prophylactic therapy with trimethoprim/
sulfamethoxazole to prevent Pneumocystis carinii
pneumonia. Trimethoprim/sulfamethoxazole is
also one of the first-line therapies for salmonello-
sis; widespread prophylactic use of this drug in
the AIDS population may have reduced the
Figure 1. Cases among persons aged > 13 years,
adjusted for delays in reporting, by quarter year,
United States, 1988–June 1996. (Points represent
quarterly prevalence; the line represents “smoothed”
prevalence. Estimates are not adjusted for incomplete
reporting of diagnosed AIDS cases or AIDS deaths.
From the Centers for Disease Control and Prevention.
Update: Trends in AIDS incidence, deaths, and
prevalence—United States, 1996. MMWR Morb
Mortal Wkly Rep 1997;46:165-73).
Figure 2. Death rates per 100,000 population for leading
causes of death among persons ages 25 to 44 years, by
year, United States, 1982–1995. (Based on underlying
causes of death reported on death certificates, using final
data for 1982–1994 and preliminary data for 1995. From
the Centers for Disease Control and Prevention. Update:
Trends in AIDS incidence, deaths, and prevalence,
United States, 1996. MMWR Morb Mortal Wkly Rep
1997;46:165-73).
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incidence of serious Salmonella infections,
although this protective effect could be
diminished in the face of increasing resistance
to this antimicrobial agent among clinical
isolates of Salmonella (10).
Fewer data are available on susceptibility of
AIDS patients to other acute bacterial foodborne
infections. While the initial impression was that
the risk for Campylobacter jejuni infections was
not higher among AIDS patients, a 35-fold
increase in the Campylobacter case rate among
persons with AIDS was noted in one study from
Los Angeles (11). Other data indicate that HIV-
positive patients can contract persistent C. jejuni
infections, with chronic diarrhea, fever, and fecal
leukocytes (12). In studies in the San Francisco
area, AIDS patients were estimated to have a
280-fold increase in incidence of listeriosis, as
compared with the general population (13). Of 98
nonpregnant adults with invasive Listeria
infection identified between November 1988 and
December 1990 in selected counties in California,
Tennessee, Georgia, and Oklahoma, 20% were
HIV-positive (13).
Before AIDS, Toxoplasma gondii was of
concern primarily because of the risk for
congenital infection in infants of mothers who
had acute illness during pregnancy. T. gondii is
now the leading cause of space-occupying cranial
lesions in persons with AIDS (14,15); data from
the 1980s suggest that 5% to 10% of AIDS
patients get toxoplasmic encephalitis (16). In an
estimated 50% of cases, Toxoplasma is transmit-
ted by food (17). In this context, Toxoplasma must
be regarded as an important emerging pathogen
in this patient population.
The AIDS epidemic has also drawn attention
to microorganisms not previously recognized as
pathogens. Perhaps the most important of these
is  Cryptosporidium.  In early investigations of
AIDS-associated diarrhea, it rapidly became
apparent that most patients were not infected
with traditional enteric pathogens. Many of these
patients were infected with Cryptosporidium; an
estimated 10% to 20% of cases of AIDS-associated
diarrhea are due to this microorganism (18). In
subsequent years, Cryptosporidium was also
recognized as the cause of intestinal infections in
healthy hosts (19); and, most recently, it has
been recognized as a major waterborne
pathogen (20). Isospora belli has also been
implicated as a cause of diarrhea in AIDS
patients, as have the microsporidia (18). More
recently, enteroaggregative Escherichia  coli and
nonpathogenic bioserovars of Yersinia
enterocolitica were associated with diarrheal
disease in AIDS cases (21,22). Further work will
determine if these latter agents are indeed
emerging pathogens in this patient population.
Increased Use of Immunosuppressive
Agents
Advances in medical treatment have resulted
in increasing numbers of immunosuppressed
patients (including patients undergoing organ
transplantation or cancer chemotherapy) and
patients with serious underlying chronic dis-
eases; these patients, too, may be at increased
risk for infection with microorganisms that might
otherwise not be recognized or associated with
serious illness. The number of new cancer cases
has steadily increased over the past 20 years. For
white males, cancers at all sites have increased
from an estimated 364 new cases/100,000
population in 1973 to 462 new cases/100,000
population in 1994; white females show an
increase from 295 new cases/100,000 population
in 1973 to 347 new cases/100,000 population in
1994 (23). Patients are also surviving longer. For
white males, the 5-year relative cancer survival
rate was 56.6% in 1986 to 1993, compared with
42% in 1974 to 1976; for white females, the 1986
to 1993 rate was 62.3%, compared with 57.6% in
1974 to 1976. While specific data are lacking,
these increases appear to have been accompanied
by increased use of chemotherapeutic regimens
and regimens that may have more toxicity than
those used in the past. The number of solid organ
transplants has also increased substantively
(Figure 3). In particular, more complex proce-
dures such as liver, heart, and lung transplants
have increased. This, in turn, has resulted in larger
numbers of chronically immunocompromised
persons in the general population.
Aside from the direct immunosuppressive
effect of the agents administered to these
patients, other associated factors may contribute
to susceptibility to infection. Many, if not most,
patients receiving chemotherapy or immunosup-
pressive agents are also treated with antimicro-
bial drugs, which can have profound effects on the
bacterial flora of the intestinal tract. These
disturbances of gut microbial ecology may
predispose to colonization and infection with
other microorganisms, some of which may have
increased virulence. Many chemotherapeutic438 Emerging Infectious Diseases Vol. 3, No. 4, October–December 1997
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agents have direct toxicity for the gut mucosa; the
resulting mucositis increases the susceptibility of
these patients to bloodstream infections with
whatever microorganisms are present in gut. The
concentration of these highly susceptible patients
on certain wards or units in a hospital may also
increase the risk for nosocomial transfer of
specific microorganisms. For example, vancomy-
cin-resistant enterococci (VRE) (which, at least in
Europe, have been associated with food [24]) have
emerged as a substantive problem in cancer
centers and transplant units (25-27). Persons
who are immunosuppressed or have serious
underlying illness are much more susceptible to
colonization and infection with the organism. In
some oncology and transplant units, more than
10% of patients are colonized or infected with
VRE (26,27), providing well-documented oppor-
tunities for transfer of the organism to other
immunosuppressed hosts in the same unit.
Cancer patients who have just undergone
chemotherapy are often profoundly neutropenic.
In this setting, especially in conjunction with the
mucositis mentioned above, virtually any micro-
organism in the intestinal tract can enter the
bloodstream and cause potentially fatal illness.
For example, it has been found that raw produce
in salads may be an important route by which
patients acquire Pseudomonas (28); as a result,
severely neutropenic patients are generally
restricted to cooked food. Salmonella infections
are reported among cancer patients, although the
relative risk for infection in this population is not
well characterized. Patients with neoplastic
disease do appear to have a substantively
increased risk for Salmonella septicemia, with
35% patients in one series having septicemia (29),
versus fewer than 1% in healthy hosts. Cancer
patients appear to be at increased risk for
invasive  Listeria infections (13). Toxoplasmosis
tends to be of particular concern among
transplant patients (30,31).
Aging of the Population
The absolute number of the elderly in the
United States is rapidly increasing, as is the
proportion of the U.S. population they comprise.
In 1950, 3.8 million persons (2.6% of the
population) were over the age of 74, as opposed to
14.7 million (5.6% of the population) in 1995 (23;
Figures 4 and 5). The elderly appear to be at a
clearly increased risk for death from foodborne
and diarrheal disease. Between 1979 and 1987,
28,538 persons in the United State had diarrhea
as an immediate or underlying cause of death;
51% of these persons were more than 74 years of
age, 27% were adults age 55 to 74, and 11% were
children under the age of 5 (32).
The increased susceptibility of the elderly to
infection and death may be due to a number of
factors. Aging results in senescence of the gut-
associated lymphoid tissue, increasing suscepti-
bility to infection. Aging may also result in a
decrease in gastric acid secretion: in one study,
stimulated acid output was reduced approxi-
mately 30% in persons aged 65 to 98, with a 40%
reduction in pepsin output (33). As a low pH of the
Figure 3. Number of organ transplants, by year and by
site, 1988–1996 (data obtained from the United
Network for Organ Sharing).
Note: Heart-lung transplants too few to be visible.
Figure 4. Number of persons >74 years of age, U.S.
population, for selected years, 1950–1990. From the
National Center for Health Statistics. Health, United
States, 1996–97 and Injury Chartbook. Hyattsville,
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stomach is a major barrier to entry of enteric
pathogens, reductions in gastric acidity can
clearly increase the susceptibility to infection.
Social factors may also influence susceptibility.
For the elderly, residence in a long-term care
facility was a major independent risk factor for
diarrheal death (32). While a number of factors
contribute to the increased risk, the communal
living environment, combined with problems of
fecal incontinence, create an environment in
which enteric and foodborne pathogens are
easily spread (32,34).
Incidence of salmonellosis and Campylobacter
diarrhea appears to be higher among the elderly
(35,36). More striking, however, is the increase in
frequency of Salmonella bacteremia as compared
with isolations from other sites: Salmonella
infections in the elderly are more likely to cause
bacteremia (37; Figure 6), which, in turn,
substantively increases the risk for death. For
example, in a recent nursing home outbreak in
Maryland, 50 (35%) of 141 residents became ill,
seven had bacteremia, nine were hospitalized
(with a median length of hospitalization of 22
days), and four died (38). E. coli O157:H7 is also a
common pathogen in nursing homes and among
the elderly. In one reported nursing home outbreak,
55 of 169 residents were affected; overall, 19
(35%) of the affected residents died (39).
Malnutrition
The above discussions have focused on issues
most relevant to the United States and other
industrialized countries. However, on a global
scale, probably the leading cause of increased
host susceptibility to infection is malnutrition.
While accurate data on the prevalence of
malnutrition are difficult to obtain, problems are
accentuated in developing countries, in areas of
political unrest, and among marginalized popula-
tions in the United States and other affluent
nations. In Mexico, according to a probabilistic
survey in 1990, 42.3% of children under 5 years of
age had some degree of malnutrition (40).
Malnutrition increases host susceptibility
through a number of mechanisms. It weakens
epithelial integrity and may have a profound
effect on cell-mediated immunity, with functional
deficiencies in immunoglobulins and defects in
phagocytosis. Malnutrition also may initiate a
“vicious cycle” of infection predisposing to
malnutrition and growth faltering, which in turn
may lead to an increased risk for further infection
(40,41). In studies in Bangladesh, malnourished
and well-nourished children had the same number
of infections with diarrheal pathogens such as
enterotoxigenic E. coli; however, diarrhea in
malnourished children was of longer duration
and had greater potential long-term nutritional
consequences (42). Overall, malnutrition appears
Figure 5. Percentage of U.S. population >74 years of age,
for selected years, 1950–1990. From National Center for
Health Statistics. Health, United States, 1996–97 and
Injury Chartbook. Hyattsville, Maryland, 1997.
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Figure 6. Ratio of blood isolates to total isolates of
Salmonella by age group of the person from whom the
isolate was obtained as reported to the Centers for
Disease Control, Atlanta, GA, in 1968–79. From
Blaser MJ, Feldman RA. Salmonella bacteremia:
reports to the Centers for Disease Control and
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to result in a 30-fold increase in the risk for
diarrhea-associated death (40).
Conclusions
Host susceptibility (and changes in the
susceptibility to infection of groups within the
general population) is a critical variable in
assessing the public health effects and under-
standing the emergence and spread of pathogenic
microorganisms. Surveillance within popula-
tions with increased susceptibility to infection
may allow identification of new pathogens before
they are recognized within the general popula-
tion. Studies designed to identify the reasons for
the increased susceptibility of a specific
population to a specific agent may reveal how a
microorganism is able (or not able) to breach
normal host defense mechanisms. Finally, from a
public health standpoint, risk management
strategies for emergent foodborne pathogens
must clearly identify and focus on populations
with increased susceptibility to infection.
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